Stockreport

WAVE Life Sciences Shares Phase 1 WVE-007 Data Showing Visceral Fat Loss, Muscle Preservation Signal [Yahoo! Finance]

Wave Life Sciences Ltd. - Ordinary Shares  (WVE) 
Last wave life sciences ltd. - ordinary shares earnings: 3/2 06:45 am Check Earnings Report
PDF WAVE Life Sciences (NASDAQ:WVE) highlighted positive interim data from the ongoing Phase 1 INLIGHT trial of WVE-007, a GalNAc-siRNA designed to treat obesity by improvi [Read more]